Pharmacological disease models
Small molecules and excitotoxic agents can be used to pharmacologically induce disease models such as epilepsy, Parkinson's Disease, catalepsy, Schizophrenia, pain and diabetes models. Researchers can save up to 50% on excitotoxic agents - they are up to half the price of other suppliers.
Resveratrol (HB4055)
Description:Potent phenolic antioxidant with many biological actions. COX-1 inhibitor.
Purity:>98%
RG 108 (HB1377)
Description:Non-nucleoside DNA methyltransferase inhibitor. Enhances iPSC generation efficiency.
Purity:>99%
Riluzole (HB6093)
Description:Na+ channel blocker / glutamate inhibitor. TREK-1 K2P channel activator.
Purity:>98%
Riluzole hydrochloride (HB0548)
Description:Na+ channel blocker / glutamate inhibitor. TREK-1 K2P channel activator. Water soluble.
Purity:>98%
Ro 25-6981 maleate (HB0554)
Description:Selective negative allosteric modulator of GluN2B (NR2B) containing NMDARs
Purity:>98%
Ro 32-0432 hydrochloride (HB4820)
Description:Potent, selective PKC inhibitor. GRK inhibitor.
Purity:>98%